Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aby Paul
Observed names:
A. Paul,
ABY PAUL
Institutions:
King George's Medical University,
Rajiv Gandhi Centre for Biotechnology
Observed institutions:
King George's Medical University,
Kerala University of Health Sciences,
Rajiv Gandhi Centre for Biotechnology
ORCID:
0000-0001-6821-6156
Observed ORCID:
0000-0001-6821-6156
OpenAlex ID:
A5032474360
Switching to Teleconsultation for Rheumatology in the Wake of the COVID-19 Pandemic: Feasibility and Patient Response in India
2020
·
Padmanabha Shenoy
, Sakir Ahmed
, et al.
·
Clinical Rheumatology
·
89
PDF
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
2021
·
Somy Cherian
, Aby Paul
, et al.
·
Rheumatology International
·
77
PDF
Postvaccination antibody titres predict protection against COVID-19 in patients with autoimmune diseases: survival analysis in a prospective cohort
2022
·
Sakir Ahmed
, Pankti Mehta
, et al.
·
Annals of the Rheumatic Diseases
·
73
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
2022
·
Teny Grace Skaria
, Anu Sreeprakash
, et al.
·
The Lancet Rheumatology
·
33
Inactivated vaccines may not provide adequate protection in immunosuppressed patients with rheumatic diseases
2021
·
Padmanabha Shenoy
, Sakir Ahmed
, et al.
·
Annals of the Rheumatic Diseases
·
16
Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 Vaccines in Patients with Autoimmune Rheumatic Diseases
2021
·
Padmanabha Shenoy
, Sakir Ahmed
, et al.
·
medRxiv
·
13
PDF
Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial
2023
·
Sreeja S. Bhat
, Sakir Ahmed
, et al.
·
Rheumatology International
·
7
Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
2022
·
Pankti Mehta
, Aby Paul
, et al.
·
Clinical Rheumatology
·
7
PDF
Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
2023
·
Libin Benny
, Pankti Mehta
, et al.
·
Rheumatology International
·
6
PDF
Effect of high-dose intravenous ascorbic acid on cancer patients following ketogenic diet
2021
·
Stelvin Sebastian
, Aby Paul
, et al.
·
Journal of Cancer Research and Therapeutics
·
6
Impact of Lockdown in India: A Case Study on Karnataka with International Model
2020
·
Stelvin Sebastian
, Aby Paul
, et al.
·
Kesmas National Public Health Journal
·
5
PDF
A Review on Deadly Nipah Virus - Prevalence and its Management
2021
·
Therese Mathew
, Badmanaban. R
, et al.
·
Research Journal of Pharmacy and Technology
·
4
Could Lockdown Really Lockdown Covid-19 Spread: A Data-based Analysis in India
2020
·
Sanjo Saijan
, Aby Paul
, et al.
·
Journal of Pharmacy Practice and Community Medicine
·
3
PDF
Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
2022
·
Aparna R. Menon
, Somy Cherian
, et al.
·
Rheumatology International
·
2
PDF
Unveiling the Potential Threat of Bacterial Oral Flora of Snake in Snake Bite Envenomation
2021
·
Aby Paul
, Joel Joby Joseph
, et al.
·
Infectious Diseases in Clinical Practice
·
2
Assessment of Lockdown Effectiveness in the Wake of COVID-19 in India Using the Auto Regressive Integrated Moving Average Model
2020
·
Joel Joby Joseph
, Aby Paul
, et al.
·
Infectious Diseases in Clinical Practice
·
2
LB0003 WITHDRAWING METHOTREXATE AFTER BOTH VERSUS ONLY SECOND DOSE OF THE ChAdOx1 nCoV-19 VACCINE IN PATIENTS WITH AUTOIMMUNE INFLAMMATORY ARTHRITIS: TWO INDEPENDENT RANDOMIZED CONTROLLED TRIALS (MIVAC I AND II)
2022
·
A. Sreekanth
, T. Skaria
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Is health needs of chronic disease patients addressed during COVID-19 lockdown in India? A cross-sectional survey
2020
·
Aby Paul
, Joel Joby
, et al.
·
1
PDF
Boosting Vaccine Response in Autoimmune Rheumatic Disease Patients With Inadequate Seroconversion: An Analysis of the Immunogenicity of Vector-Based and Inactivated Vaccines
2024
·
Anuroopa Vijayan
, Aswathy Sukumaran
, et al.
·
Cureus
PDF
A retrospective study of clinical profile of viper bite cases in selected hospitals in central kerala
2023
·
Anumol Saju
, Antriya Annie Tom
, et al.
·
Journal of Innovations in Applied Pharmaceutical Science (JIAPS)
PDF
Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
2022
·
Pankti Mehta
, Sakir Ahmed
, et al.
·
The Lancet Rheumatology
Humoral Responses to SARS-CoV-2 Vaccination in Rituximab-Treated Patients Depend on Peripheral B Cell Re-population Rather Than the Timings of the Dosing
2022
·
Rashwith Umesh
, Aby Paul
, et al.
·
Indian Journal of Rheumatology
Effects of the Second Dose of COVID-19 Vaccines in Patients with Autoimmune Rheumatic Diseases with Hybrid Immunity
2022
·
Sakir Ahmed
, Pankti Mehta
, et al.
·
SSRN Electronic Journal
Shifting to Telemedicine Practice During Covid-19 Lock Down Days: Impact on Chronic Disease Patients.
2021
·
Aby Paul
, Joel Joby Joseph.
, et al.
·
Journal of Bio Innovation
Chromoblastomycosis
2020
·
Joel Joby Joseph
, Aby Paul
, et al.
·
Infectious Diseases in Clinical Practice
Show more works
View as search
Works count:
30
Citation count:
347
H-index:
7
I10-index:
6
Year
Topic
Type